-
GT-02287 Shows Promise in Parkinson's Patients with and Without GBA1 Mutation
06 Aug 2025 12:57 GMT
In an interview with Pharmaceutical Executive, Gene Mack, CEO, GAIN Therapeutics, shared promising updates on the company’s lead candidate, GT-02287, a novel therapy in development for Parkinson’s disease. Enrollment for the Phase Ib open-label trial …
-
Low oxygen environment protects brain and restores movement in mice with Parkinson's
06 Aug 2025 13:08 GMT
Researchers from the Broad Institute and Mass General Brigham have shown that a low-oxygen environment - similar to the thin air found at Mount Everest base camp - can protect the brain and restore movement in mice with Parkinson's-like disease.
The …
-
Sumitomo Pharma files for approval of stem cell Parkinson's treatment
06 Aug 2025 06:43 GMT
Pharmaceuticals
Therapy improved motor function in 4 of 6 patients in clinical trial
Induced pluripotent stem cell technology was developed in Japan in 2007, but progress on developing treatments for diseases has been slow. (Photo obtained by Nikkei)
…
-
Pharma Pulse 8/6/25: GT-02287 Shows Promise in Parkinson's Patients with and Without GBA1 Mutation; How Remote Monitoring Enhances Trial Efficiency and Patient Safety
06 Aug 2025 11:27 GMT
GT-02287 Shows Promise in Parkinson's Patients with and Without GBA1 Mutation
In an interview with Pharmaceutical Executive, GAIN Therapeutics CEO Gene Mack shared that GT-02287, originally developed for Parkinson’s patients with the GBA1 mutation, is …
-
How Pharma Can Navigate Innovation and Cost Pressures in the GLP-1 Era
06 Aug 2025 11:27 GMT
In a video interview with Pharma Commerce, Philip Sclafani, PwC's pharmaceutical and life sciences lead, he describes how the One Big Beautiful Bill Act (OBBBA) is expected to significantly influence prescription drug spending by reshaping access and …
-
Japan firm seeks approval for stem cell treatment for Parkinson's
06 Aug 2025 03:05 GMT
Tokyo: Japanese drugmaker Sumitomo Pharma said Tuesday it is seeking approval for a Parkinson's disease treatment that transplants stem cells into a patient's brain, following a successful clinical trial.
The company applied to Japanese regulators …
-
PTSD Drug Discovery May Help Patients Let Go of Trauma
04 Aug 2025 17:10 GMT
A promising new drug could help people living with post-traumatic stress disorder (PTSD) finally let go of trauma.
This is the discovery of scientists at the Institute of Basic Science (IBS) and Ewha Womans University in South Korea who have identified a …
-
Do Millipedes Hold Key to Pain Relief, Parkinson's Treatment?
02 Aug 2025 13:02 GMT
-
Prescription of Love, Mindfulness, and Hope in Parkinson Disease Care: Esther Labib-Kiyarash, MSHA, CPHQ
06 Aug 2025 06:46 GMT
WATCH TIME: 6 minutes | Captions are auto-generated and may contain errors.
"I've been to a lot of neurologists, easily half a dozen, if not more, by now, and you definitely see which ones have hope and which ones don't. I've seen it in …
-
Ozzy Osbourne's cause of death released
06 Aug 2025 02:39 GMT
Osbourne died on July 22 at age 76, just days after taking the stage for the last time.
WASHINGTON — Heavy metal legend Ozzy Osbourne’s cause of death has been officially confirmed.
A death certificate obtained by The New York Times and The Sun lists …